Supernus Pharmaceuticals, Inc.
SUPN
$50.81
$0.280.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.12% | -31.95% | -30.27% | 50.52% | 55.71% |
| Total Receivables | 25.09% | 32.18% | 17.77% | -7.65% | -1.42% |
| Inventory | 76.16% | 51.74% | 24.10% | -35.41% | -34.17% |
| Prepaid Expenses | 169.93% | 81.02% | 126.53% | 35.61% | 21.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.40% | -6.11% | -7.20% | 25.02% | 26.32% |
|
|
|||||
| Total Current Assets | 6.40% | -6.11% | -7.20% | 25.02% | 26.32% |
| Net Property, Plant & Equipment | 6.98% | 3.39% | 3.76% | -17.71% | -20.26% |
| Long-term Investments | 3.12% | 6.72% | 1.76% | 0.00% | 0.00% |
| Goodwill | 3.12% | 6.72% | 1.76% | 0.00% | 0.00% |
| Total Other Intangibles | 9.48% | 9.11% | 15.43% | -14.00% | -13.39% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 859.01% | 990.57% | 480.80% | 50.95% | -24.60% |
| Total Assets | 11.39% | 6.18% | 5.74% | 5.06% | 3.31% |
|
|
|||||
| Total Accounts Payable | 43.82% | -41.64% | 27.93% | 77.51% | -50.88% |
| Total Accrued Expenses | 26.53% | 20.87% | 34.30% | 6.57% | 7.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 79.15% | 54.04% | 16.94% | -23.67% | -34.99% |
| Total Finance Division Other Current Liabilities | 41.95% | 6.31% | -22.29% | -32.64% | -29.72% |
| Total Other Current Liabilities | 41.95% | 6.31% | -22.29% | -32.64% | -29.72% |
| Total Current Liabilities | 32.71% | 15.65% | 13.42% | -7.22% | -10.42% |
|
|
|||||
| Total Current Liabilities | 32.71% | 15.65% | 13.42% | -7.22% | -10.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.79% | 10.89% | 8.63% | -19.51% | -20.08% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 133.56% | 78.31% | -46.84% | -60.04% | -69.15% |
| Total Liabilities | 33.90% | 17.63% | 10.29% | -11.13% | -15.56% |
|
|
|||||
| Common Stock & APIC | 15.47% | 13.43% | 13.26% | 9.18% | 8.78% |
| Retained Earnings | -5.33% | -6.93% | -3.53% | 12.83% | 12.83% |
| Treasury Stock & Other | -60.38% | 76.72% | -191.03% | 46.24% | 70.22% |
| Total Common Equity | 4.47% | 2.51% | 4.22% | 11.12% | 10.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.47% | 2.51% | 4.22% | 11.12% | 10.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.47% | 2.51% | 4.22% | 11.12% | 10.93% |
|
|
|||||